A randomized phase Ib/II study of intermittent androgen deprivation therapy plus nivolumab with or without interleukin-8 blockade in men with hormone-sensitive prostate cancer (MAGIC-8).

Authors

• William Kelly

Publication/Presentation Date

6-2022

Volume

40

Issue

16

Published In/Presented At

DOI: 10.1200/JCO.2022.40.16_suppl.5082

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article